Beijing Scitop Bio Tech Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 36.95%

Beijing Scitop Bio Tech Co Ltd (300858) has an Asset Resilience Ratio of 36.95% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Beijing Scitop Bio Tech Co Ltd (300858) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥717.09 Million

≈ $104.93 Million USD Cash + Short-term Investments

Total Assets

CN¥1.94 Billion

≈ $284.01 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Beijing Scitop Bio Tech Co Ltd's Asset Resilience Ratio has changed over time. See Beijing Scitop Bio Tech Co Ltd shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Beijing Scitop Bio Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Beijing Scitop Bio Tech Co Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥717.09 Million	36.95%
Total Liquid Assets	CN¥717.09 Million	36.95%

Asset Resilience Insights

Very High Liquidity: Beijing Scitop Bio Tech Co Ltd maintains exceptional liquid asset reserves at 36.95% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Beijing Scitop Bio Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Scitop Bio Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Beijing Scitop Bio Tech Co Ltd (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Beijing Scitop Bio Tech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	15.49%	CN¥296.73 Million ≈ $43.42 Million	CN¥1.92 Billion ≈ $280.31 Million	-19.61pp
2023-12-31	35.10%	CN¥635.26 Million ≈ $92.96 Million	CN¥1.81 Billion ≈ $264.87 Million	+19.39pp
2022-12-31	15.70%	CN¥281.17 Million ≈ $41.14 Million	CN¥1.79 Billion ≈ $262.01 Million	+6.91pp
2021-12-31	8.80%	CN¥91.55 Million ≈ $13.40 Million	CN¥1.04 Billion ≈ $152.29 Million	-8.06pp
2020-12-31	16.85%	CN¥168.40 Million ≈ $24.64 Million	CN¥999.25 Million ≈ $146.22 Million	--

pp = percentage points

About Beijing Scitop Bio Tech Co Ltd

SHE:300858 China Biotechnology

Market Cap

$688.25 Million

CN¥4.70 Billion CNY

Market Cap Rank

#10932 Global

#3231 in China

Share Price

CN¥17.85

Change (1 day)

-2.41%

52-Week Range

CN¥13.92 - CN¥25.45

All Time High

CN¥35.93